The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...
Boehringer Ingelheim (Ingelheim, Germany) for Viramune (nevirapine) and access to the generics for Bristol Meyer Squibb's (Princeton, NJ, USA) Zerit (stavudine, 2′,3′-didehydro-, 3′-deoxy ...
Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...
Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...
Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...
The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis ...
Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...
Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...
Dr. Schermerhorn received his VMD from the University of Pennsylvania and completed an internship at South Shore Veterinary Associates and a small animal internal medicine residency at Cornell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback